To elucidate the functional significance of ZSCAN18 in GC, we first upregulated ZSCAN18 in AGS and NCI-N87 cells, and overexpression of ZSCAN18 was identified by qRT-PCR and western blot (Fig. 3A). Here, ZSCAN18 is linked to gastric cancer.